Lapatinib 2-Fluoro Impurity;1393112-45-2

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• 
  

• Product Number: L079005
  English Name: Lapatinib 2-Fluoro Impurity
  English Alias: N-(3-chloro-4-((2-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine
  CAS Number: 1393112-45-2
  Molecular Formula: C29H26ClFN4O4S
  Molecular Weight: 581.06
• 
  
• Product Advantages: Lapatinib 2-Fluoro Impurity has high purity and stable chemical properties. Its structure has been confirmed by rigorous spectroscopic analysis (such as nuclear magnetic resonance and mass spectrometry), and it remains stable and uniform under different experimental conditions and storage environments. As a reference substance, it can be accurately used for Lapatinib impurity detection, ensuring accurate, reliable, and highly reproducible detection results. It provides strong support for pharmaceutical quality research and quality control, effectively assisting in quality monitoring during drug research, development, and production.
• 
  
• Application Fields:
• 
  

• Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Lapatinib bulk drugs and formulations, ensuring that the sensitivity and specificity of the detection methods meet pharmaceutical quality standards and facilitating drug quality control.

• Process Optimization: During the production of Lapatinib, by monitoring the content of this impurity and tracing its generation stage, it assists in optimizing the synthesis process, reducing impurity formation, and improving product quality and production efficiency.

• Stability Studies: In drug stability tests, it analyzes the changes of this impurity under different storage conditions (such as temperature, humidity, light), providing key data for determining the shelf life and suitable storage conditions of drugs.

• 
  
• Background Description: Lapatinib is an important targeted drug for the treatment of HER2-positive breast cancer. In its research, development, production, and quality control, impurity research is a key link to ensure drug safety and effectiveness. The presence of impurities may affect drug efficacy and even cause potential toxic and side effects. As a related impurity of Lapatinib, in-depth research on Lapatinib 2-Fluoro Impurity helps to comprehensively evaluate the quality of Lapatinib drugs, ensure the safety and effectiveness of clinical medication, and improve the drug quality evaluation system.
• 
  
• Research Status: Currently, research on Lapatinib 2-Fluoro Impurity continues to progress. In terms of detection technology, advanced methods such as Ultra-Performance Liquid Chromatography - Tandem Mass Spectrometry (UPLC - MS/MS) and high-resolution mass spectrometry are continuously being explored to achieve precise detection of this impurity at trace levels. In the study of impurity generation mechanisms, the formation causes and influencing factors are deeply analyzed by simulating drug synthesis reactions and storage environments, providing a theoretical basis for controlling impurities from the source. At the same time, research on the interaction between this impurity and Lapatinib and its impact on drug efficacy and safety is also gradually being carried out, aiming to further improve the comprehensive understanding of the quality of Lapatinib drugs and guide rational clinical medication.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!